SCHEMBL24674406

SCHEMBL24674406

CCCc1nc2ccccc2n1-c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccccc4)cc3)c3cc(-c4ccccc4)ccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PPARG P37231 2/20 0.45
PDE10A Q9Y233 5/20 0.43
BLM P54132 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 2/20 0.43
USP2 O75604 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.42
POLB P06746 1/20 0.41
NTRK1 P04629 1/20 0.40
NTRK2 Q16620 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24674393 1.00 CYP1A2 (0.47) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL10354033 1.00 CYP1A2 (0.47) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL24674114 1.00 CYP1A2 (0.47) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL2604824 0.94 MEN1 (0.51) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL2604841 0.94 MEN1 (0.51) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL24674314 0.94 PDE10A (0.46) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL24674113 0.94 LMNA (0.51) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL24674273 0.94 LMNA (0.51) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL24674391 0.94 LMNA (0.51) CYP1A2MEN1KMT2ACYP3A4CYP2D6
SCHEMBL24674385 0.91 MEN1 (0.45) CYP1A2MEN1KMT2APPARGPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220384734-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220384734-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE MCOLN2, RER1, L1CAM CYP1A2 2514/4885MEN1 228/4885KMT2A 893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.